The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 12,008.00
Ask: 12,012.00
Change: 674.00 (5.94%)
Spread: 4.00 (0.033%)
Open: 11,890.00
High: 12,096.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin

Sun, 17th Jan 2021 18:28

(Adds details on doses, Sao Paulo governor comments)

By Jamie McGeever and Pedro Fonseca

BRASILIA/RIO DE JANEIRO, Jan 17 (Reuters) - Brazilian health
regulator Anvisa on Sunday approved emergency use of COVID-19
vaccines from China's Sinovac Biotech Ltd and Britain's
AstraZeneca, clearing the way for immunizations as the
pandemic enters a deadly second wave.

Minutes after Anvisa's board voted unanimously to approve
both vaccines, Monica Calazans, a 54-year-old nurse in Sao
Paulo, became the first person to be inoculated in the country,
receiving the Chinese vaccine known as CoronaVac.

President Jair Bolsonaro, a coronavirus skeptic who has
refused to take a vaccine himself, is under growing pressure to
start inoculations in Brazil, which has lost more than 200,000
to COVID-19 – the worst death toll outside the United States.
(Graphic: https://tmsnrt.rs/34pvUyi)

Delays with vaccine shipments and testing results have held
up vaccinations in the country, once a global leader in mass
immunizations and now a regional laggard after countries such as
Chile and Mexico started giving shots last month.

Bolsonaro's government aims to kick off a national
immunization program this week but is waiting on shipments of
the AstraZeneca vaccine at the center of its plans. That has
added to public frustration and offered a political rival the
chance to upstage the right-wing president.

Sao Paulo Governor Joao Doria, who oversees the Butantan
biomedical center that is partnered with Sinovac in Brazil, said
Anvisa's decision was a triumph for science as he gave the
go-ahead for the first vaccination in his state.

"A victory for science. A victory for life. A victory for
Brazil," Doria tweeted.

Bolsonaro, for whom Doria is a potential center-right rival
to his 2022 re-election efforts, has taunted the governor over
CoronaVac's disappointing 50% efficacy in Brazilian trials. But
the federal Health Ministry has agreed to acquire and distribute
the shot for the national immunization drive.

Health Minister Eduardo Pazuello told a news conference that
the rush to start vaccinating immediately was an illegal
"marketing ploy" and the government would start distributing the
vaccines to states on Monday, with the nationwide immunization
plan beginning on Wednesday.

Brazil could eventually vaccinate 1 million people a day, he
said.

Adding to the urgency for vaccinations, a second wave of the
outbreak in Brazil is snowballing as the country confronts a
new, potentially more contagious variant of the coronavirus that
originated in Amazonas state and prompted Britain and Italy to
bar entry to Brazilians.

Butantan, which is set up to fill and finish CoronaVac doses
on its production line, plans to supply 46 million doses of the
two-dose shot by April, the institute said in a statement. Some
6 million of those are ready to go.

The federally funded Fiocruz institute is still waiting for
a delayed shipment of the active ingredient in the AstraZeneca
vaccine for finishing on a Rio de Janeiro assembly line.

The Health Ministry has scrambled to line up 2 million ready
doses of the AstraZeneca vaccine from India, but officials there
have suggested it may take weeks to approve exports. Pazuello
said on Sunday he expected the doses from India this week.

(Reporting by Eduardo Simoes in Sao Paulo, Pedro Fonseca in Rio
de Janeiro, Jamie McGeever and Ricardo Brito in Brasilia;
Editing by Brad Haynes, Lisa Shumaker and Peter Cooney)

More News
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.